You can find the annual or quarterly income statement of Spruce Biosciences Inc here for insights into the performance and operational efficiency of Spruce Biosciences Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Total revenue

-100.00%0.00

-75.86%697.00K

-80.41%602.00K

-25.64%1.61M

1.93%2.00M

--2.89M

--3.07M

--2.17M

--1.96M

----

Revenue

-100.00%0.00

-75.86%697.00K

-80.41%602.00K

-25.64%1.61M

1.93%2.00M

--2.89M

--3.07M

--2.17M

--1.96M

----

Operating expenses

-55.19%11.10M

-17.79%8.23M

-76.88%2.69M

-0.98%14.49M

76.29%24.77M

-40.17%10.01M

-27.83%11.65M

-3.48%14.63M

16.03%14.05M

44.77%16.73M

35.81%16.14M

29.23%15.16M

32.57%12.11M

1.38%11.56M

1.43%11.88M

19.52%11.73M

9.60%9.13M

19.26%11.40M

--11.71M

--9.82M

--8.34M

--9.56M

R&D expenses

-80.87%4.10M

-23.54%5.01M

-105.32%-430.00K

5.04%10.84M

93.31%21.46M

-51.43%6.55M

-38.37%8.09M

-11.91%10.32M

25.58%11.10M

53.50%13.49M

44.88%13.13M

37.66%11.71M

41.24%8.84M

2.14%8.79M

-0.65%9.06M

26.72%8.51M

7.64%6.26M

10.79%8.61M

--9.12M

--6.71M

--5.81M

--7.77M

Depreciation, depletion, and amortization

-44.44%5.00K

-70.00%3.00K

-41.67%7.00K

-60.00%6.00K

-43.75%9.00K

-41.18%10.00K

-33.33%12.00K

-21.05%15.00K

-33.33%16.00K

-26.09%17.00K

100.00%18.00K

-9.52%19.00K

20.00%24.00K

27.78%23.00K

-47.06%9.00K

61.54%21.00K

100.00%20.00K

125.00%18.00K

--17.00K

--13.00K

--10.00K

--8.00K

Operating profit

53.89%-11.10M

12.53%-8.23M

73.18%-2.69M

-14.72%-14.49M

-115.64%-24.07M

31.12%-9.41M

28.17%-10.04M

4.29%-12.63M

7.81%-11.16M

-18.18%-13.66M

-17.59%-13.97M

-12.49%-13.20M

-32.57%-12.11M

-1.38%-11.56M

-1.43%-11.88M

-19.52%-11.73M

-9.60%-9.13M

-19.26%-11.40M

---11.71M

---9.82M

---8.34M

---9.56M

Net non-operating interest income (expenses)

Non-operating interest expense

-89.29%6.00K

-73.24%19.00K

-65.06%29.00K

-62.89%36.00K

-47.17%56.00K

-40.34%71.00K

-34.65%83.00K

-25.95%97.00K

-17.83%106.00K

8.18%119.00K

35.11%127.00K

50.57%131.00K

46.59%129.00K

25.00%110.00K

17.50%94.00K

-2.25%87.00K

12.82%88.00K

11.39%88.00K

--80.00K

--89.00K

--78.00K

--79.00K

Special income (expenses)

---3.50M

----

Other non-operating income (expenses)

-107.01%-40.00K

-95.54%36.00K

-30.28%654.00K

-55.93%487.00K

-56.74%571.00K

-43.22%808.00K

-26.43%938.00K

105.01%1.10M

20.55%1.32M

434.96%1.42M

1125.96%1.27M

829.31%539.00K

2707.69%1.09M

548.78%266.00K

420.00%104.00K

205.26%58.00K

-48.00%39.00K

-19.61%41.00K

--20.00K

--19.00K

--75.00K

--51.00K

Income before tax

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

---9.89M

---8.34M

---9.59M

Income tax

----

--0.00

----

Income after tax

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

---9.89M

---8.34M

---9.59M

Net income from continuous operations

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

---9.89M

---8.34M

---9.59M

Net income attributable to controlling interests

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

---9.89M

---8.34M

---9.59M

Net income attributable to common shareholders

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

---11.77M

---9.89M

---8.34M

---9.59M

Basic earnings per share

-1887.74%-11.28

-6846.96%-14.58

-117479.25%-262.25

-8371.47%-23.96

-132.71%-0.57

30.82%-0.21

29.48%-0.22

29.45%-0.28

48.42%-0.24

37.29%-0.30

37.41%-0.32

19.91%-0.40

-20.79%-0.47

1.22%-0.48

-0.13%-0.51

-17.91%-0.50

-4.56%-0.39

-13.76%-0.49

---0.50

---0.42

---0.37

---0.43

Diluted earnings per share

-1887.74%-11.28

-6846.96%-14.58

-117479.25%-262.25

-8371.47%-23.96

-132.71%-0.57

30.82%-0.21

29.48%-0.22

29.45%-0.28

48.42%-0.24

37.29%-0.30

37.41%-0.32

19.91%-0.40

-20.79%-0.47

1.22%-0.48

-0.13%-0.51

-17.91%-0.50

-4.56%-0.39

-13.76%-0.49

---0.50

---0.42

---0.37

---0.43

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

